# A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401

> **NCT05195541** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cutia Therapeutics（Wuxi）Co.,Ltd** · enrollment: 48 (actual)

## Conditions studied

- Safety

## Interventions

- **DRUG:** CU-20401

## Key facts

- **NCT ID:** NCT05195541
- **Lead sponsor:** Cutia Therapeutics（Wuxi）Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-27
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195541, "A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05195541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*